{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:59:53Z","timestamp":1795042793860,"version":"4.10.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109254h0001"],"award-info":[{"award-number":["17ek0109254h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Japanese association for complement research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated disease that manifests as the triad of thrombotic microangiopathy. We identified two aHUS patients with neither anti-complement factor H (CFH) antibodies nor causative variants of seven aHUS-related genes (<jats:italic>CFH<\/jats:italic>, <jats:italic>CFI<\/jats:italic>, <jats:italic>CFB<\/jats:italic>, <jats:italic>C3<\/jats:italic>, <jats:italic>MCP<\/jats:italic>, <jats:italic>THBD<\/jats:italic>, and <jats:italic>DGKE<\/jats:italic>); however, their plasma showed increased levels of hemolysis by hemolytic assay, which strongly suggests CFH-related abnormalities. Using a copy number variation (CNV) analysis of the <jats:italic>CFH\/CFHR<\/jats:italic> gene cluster, we identified <jats:italic>CFH-CFHR1<\/jats:italic> hybrid genes in these patients. We verified the absence of aHUS-related abnormal CNVs of the <jats:italic>CFH<\/jats:italic> gene in control genomes of 2036 individuals in the general population, which suggests that pathogenicity is related to these hybrid genes. Our study emphasizes that, for patients suspected of having aHUS, it is important to perform an integrated analysis based on a clinical examination, functional analysis, and detailed genetic investigation.<\/jats:p>","DOI":"10.1038\/s10038-023-01129-1","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T04:59:42Z","timestamp":1675918782000},"page":"427-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome"],"prefix":"10.1038","volume":"68","author":[{"given":"Yuka","family":"Sugawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4292-8785","authenticated-orcid":false,"given":"Masao","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Minegishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-9436","authenticated-orcid":false,"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"1129_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI71866","volume":"124","author":"Q Chen","year":"2014","unstructured":"Chen Q, Wiesener M, Eberhardt HU, Hartmann A, Uzonyi B, Kirschfink M, et al. Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J Clin Invest. 2014;124:145\u201355.","journal-title":"J Clin Invest"},{"key":"1129_CR2","first-page":"2","volume":"14","author":"J Laurence","year":"2016","unstructured":"Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Clin Adv Hematol Oncol. 2016;14:2\u201315.","journal-title":"Clin Adv Hematol Oncol"},{"key":"1129_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10157-016-1276-6","volume":"20","author":"H Kato","year":"2016","unstructured":"Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, et al. Clinical guides for atypical hemolytic uremic syndrome in Japan. Clin Exp Nephrol. 2016;20:536\u201343.","journal-title":"Clin Exp Nephrol"},{"key":"1129_CR4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s10157-018-1549-3","volume":"22","author":"M Fujisawa","year":"2018","unstructured":"Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, et al. Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome. Clin Exp Nephrol. 2018;22:1088\u201399.","journal-title":"Clin Exp Nephrol"},{"key":"1129_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0161-5890(00)00024-9","volume":"37","author":"DA Male","year":"2000","unstructured":"Male DA, Ormsby RJ, Ranganathan S, Giannakis E, Gordon DL. Complement factor H: Sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. Mol Immunol. 2000;37:41\u201352.","journal-title":"Mol Immunol"},{"key":"1129_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1086\/318201","volume":"68","author":"D P\u00e9rez-Caballero","year":"2001","unstructured":"P\u00e9rez-Caballero D, Gonz\u00e1lez-Rubio C, Gallardo ME, Vera M, L\u00f3pez-Trascasa M, Rodr\u00edguez de C\u00f3rdoba S, et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet. 2001;68:478\u201384.","journal-title":"Am J Hum Genet"},{"key":"1129_CR7","doi-asserted-by":"publisher","first-page":"E4433","DOI":"10.1073\/pnas.1717600115","volume":"115","author":"S Cantsilieris","year":"2018","unstructured":"Cantsilieris S, Nelson BJ, Huddleston J, Baker C, Harshman L, Penewit K, et al. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family. Proc Natl Acad Sci USA. 2018;115:E4433\u2013E42.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1129_CR8","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","volume":"3","author":"JP Venables","year":"2006","unstructured":"Venables JP, Strain L, Routledge D, Bourn D, Powell HM, Warwicker P, et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med. 2006;3:e431.","journal-title":"PLoS Med"},{"key":"1129_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/ndt\/gfq658","volume":"26","author":"TK Maga","year":"2011","unstructured":"Maga TK, Meyer NC, Belsha C, Nishimura CJ, Zhang Y, Smith RJH. A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome. Nephrol Dial Transpl. 2011;26:739\u201341.","journal-title":"Nephrol Dial Transpl"},{"key":"1129_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2011-03-339903","volume":"119","author":"NJ Francis","year":"2012","unstructured":"Francis NJ, McNicholas B, Awan A, Waldron M, Reddan D, Sadlier D, et al. A novel hybrid CFH\/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood. 2012;119:591\u2013601.","journal-title":"Blood"},{"key":"1129_CR11","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1681\/ASN.2015010100","volume":"27","author":"RC Challis","year":"2016","unstructured":"Challis RC, Araujo GSR, Wong EKS, Anderson HE, Awan A, Dorman AM, et al. A de novo deletion in the regulators of complement activation cluster producing a hybrid complement factor H\/complement factor H-related 3 gene in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2016;27:1617\u201324.","journal-title":"J Am Soc Nephrol"},{"key":"1129_CR12","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00467-013-2560-2","volume":"28","author":"SJ Eyler","year":"2013","unstructured":"Eyler SJ, Meyer NC, Zhang Y, Xiao X, Nester CM, Smith RJH. A novel hybrid CFHR1\/CFH gene causes atypical hemolytic uremic syndrome. Pediatr Nephrol. 2013;28:2221\u20135.","journal-title":"Pediatr Nephrol"},{"key":"1129_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1681\/ASN.2013121339","volume":"26","author":"E Valoti","year":"2015","unstructured":"Valoti E, Alberti M, Tortajada A, Garcia-Fernandez J, Gastoldi S, Besso L, et al. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. J Am Soc Nephrol. 2015;26:209\u201319.","journal-title":"J Am Soc Nephrol"},{"key":"1129_CR14","doi-asserted-by":"publisher","first-page":"e0124655","DOI":"10.1371\/journal.pone.0124655","volume":"10","author":"Y Yoshida","year":"2015","unstructured":"Yoshida Y, Miyata T, Matsumoto M, Shirotani-Ikejima H, Uchida Y, Ohyama Y, et al. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan. PLoS One. 2015;10:e0124655.","journal-title":"PLoS One"},{"key":"1129_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ije\/dyz169","volume":"49","author":"S Kuriyama","year":"2020","unstructured":"Kuriyama S, Metoki H, Kikuya M, Obara T, Ishikuro M, Yamanaka C, et al. Cohort profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective. Int J Epidemiol. 2020;49:18\u201319m.","journal-title":"Int J Epidemiol"},{"key":"1129_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","volume":"29","author":"M J\u00f3zsi","year":"2008","unstructured":"J\u00f3zsi M, Zipfel PF. Factor H family proteins and human diseases. Trends Immunol. 2008;29:380\u20137.","journal-title":"Trends Immunol"},{"key":"1129_CR17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.ekir.2021.03.885","volume":"6","author":"G Ardissino","year":"2021","unstructured":"Ardissino G, Longhi S, Porcaro L, Pintarelli G, Strumbo B, Capone V, et al. Risk of atypical HUS among family members of patients carrying complement regulatory gene abnormality. Kidney Int Rep. 2021;6:1614\u201321.","journal-title":"Kidney Int Rep"},{"key":"1129_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/jmedgenet-2014-102498","volume":"51","author":"FH Sansbury","year":"2014","unstructured":"Sansbury FH, Cordell HJ, Bingham C, Bromilow G, Nicholls A, Powell R, et al. Factors determining penetrance in familial atypical haemolytic uraemic syndrome. J Med Genet. 2014;51:756\u201364.","journal-title":"J Med Genet"},{"key":"1129_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-023-01129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-023-01129-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-023-01129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T23:04:58Z","timestamp":1684969498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-023-01129-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1038\/s10038-023-01129-1","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Masaomi Nangaku receives honoraria for lectures from Alexion Pharma and honoraria for lectures and subsidies from Chugai Pharma.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}